Patients with previous history of other neoplasms tended to present with increased circulating IL-6 levels ((median 3.2 pg/mL (IQR 74.3) vs. 0 pg/mL (IQR 2.90), p = 0.06). This evidence concerns the gene IL6 and neoplasm.